Latest Compliance News

Paladin Energy reported a strong half-year performance with uranium sales revenue climbing to US$138.3 million, driven by ramp-up at its Namibian mine and significant progress on Canadian development projects.

Manuka Resources has affirmed the material significance of a draft decision by New Zealand’s EPA declining consent for its Taranaki VTM Project, clarifying its disclosure timeline and compliance with ASX rules amid recent share price volatility.

Middle Island Resources has revealed extensive polymetallic soil anomalies spanning 5km at its Tisovik target in Serbia’s Bobija Project, signalling a promising expansion of mineralisation. The company plans to intensify exploration activities starting March 2026 to unlock the area’s full potential.

Titanium Sands Limited has responded to ASX inquiries following a sharp share price drop and increased trading volume, confirming no undisclosed price-sensitive information. The company highlighted an unrelated Sri Lankan Supreme Court petition on illegal mining near its pending Mannar Island project.

Viva Leisure Limited has reported a robust half-year performance for the period ending 31 December 2025, with revenues climbing 17.6% and profit after tax soaring by 167.8%. The company’s strategic focus on franchise expansion and technology innovation is driving growth.

Oneview Healthcare reported a robust 21% increase in revenue for FY2025, driven by recurring revenue growth and new customer acquisitions. The company is advancing AI-powered solutions and targeting operational breakeven in 2026.

EROAD Limited’s CEO Mark Heine has announced his resignation effective June 2026, concluding an 11-year tenure marked by significant company growth across multiple regions.

Critical Resources Limited has successfully completed the first tranche of its capital raising, securing $1.605 million through a substantial share and option issuance. The company now awaits shareholder approval for the second tranche, which involves director participation.

Oakridge International Limited has reported a striking turnaround in its half-year results, posting a profit after tax of $172,239 against a prior loss, driven by strong sales and product innovation in healthcare technology.

Cobre Limited has voluntarily suspended its ASX trading to finalise details of a significant acquisition and placement, with an announcement expected imminently.

ECS Botanics has partnered with Nimbus Health to distribute its medicinal cannabis products across Germany, marking its entry into Europe's largest cannabis market. The launch of the OzSun brand is set for April 2026, with premium Terphogz strains to follow later in the year.

Cyclopharm Limited has completed the initial phase of a $14 million share placement, issuing nearly 9.5 million shares at 95 cents each, with the remaining shares set for issuance later this month.